IGF1 LR3 provides more direct receptor activation with fewer endocrine effects, though head-to-head comparisons are limited
Br J Dermatol 171(1):155161 Yang J, Wang Z, Zhang X (2019) GLP-1 receptor agonist impairs keratinocytes inflammatory signals by activating AMPK
When choosing between compounded and FDA-approved weight loss treatments, patients should consider safety, effectiveness, and regulation
Although retatrutide is showing promising results in clinical trials, it has not yet been FDA approved, so conclusions cant be made around it being the best weight loss solution
This modulation of inflammatory signaling occurs through activation of the PI3K/AKT pathway, which possesses intrinsic anti-inflammatory properties including inhibition of pro-inflammatory cytokine release and enhancement of cellular stress resistance